Latest news with #Veozah.Menopause

Yahoo

Menopause Market Size, Share & Trends Analysis Report and Growth Forecasts 2025-2030: Menopause Market Projected To Reach $24.35 Billion By 2030 With A 5.42% CAGR

The Menopause Market is projected to reach USD 24.35 billion by 2030, growing at a CAGR of 5.42%. Market drivers include increasing menopause awareness, dietary supplement research, and FDA drug approvals. Key players like Morphus and Amyris, Inc. are innovating treatments, while regions like North America see high demand for nutrients in older women. The comprehensive report offers market intelligence, forecasts, and trends for informed decision-making. Menopause Market Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "Menopause Market Size, Share & Trends Analysis Report by Treatment (Dietary Supplements, OTC Pharma Products), Region (NA, Europe, APAC, Latin America, MEA) with Growth Forecasts, 2025-2030" report has been added to Menopause Market was valued at USD 17.79 billion in 2024, and is projected to reach USD 24.35 billion by 2030, rising at a CAGR of 5.42%. The market growth is expected to be driven by factors such as rising prevalence of post-menopausal syndrome, increasing awareness regarding menopause-associated health aspects, and high adoption of women's health apps. The market is projected to be driven by rising research supporting the benefits of dietary supplements over HRT. Many dietary supplements are available in the market that contain ingredients such as black cohosh, red clover, soy isoflavones, and amberen. Manufacturers are also involved in developing new products to address menopausal symptoms. For instance, Morphus launched several supplement products in 2023 to address some of the most pressing symptoms of menopause and perimenopause. The first product launched was FiberUs, an unflavored soluble prebiotic fiber made from guar demand for dietary supplements and OTC pharma products increased in the post-pandemic scenario due to the delays in physician's appointments, rescheduling of hormonal replacement therapies, and the easy availability of OTC drugs from retail pharmacies and online channels. However, the market is now stabilizing due to the ease of restrictions and the increasing awareness of surge in FDA approvals for drugs aimed at treating hot flashes and night sweats is a significant factor propelling the growth of the market. In May 2023, the FDA gave their approval for a new non-hormonal medication to address night sweats and hot flashes that are often experienced by individuals during menopause. This prescription drug, called fezolinetant, is specifically designed for those who are unable to take hormonal therapy and who are struggling with vasomotor symptoms, such as breast cancer survivors. The medication is branded under the name Market Report Highlights Based on treatment, the dietary supplements treatment segment dominated the market in 2024 and is expected to witness the fastest growth during the forecast period. The growth of the segment can be attributed to several factors, including the increasing geriatric population and the launch of innovative products. For instance, in April 2021, Pulmuone, a South Korea-based dietary supplement firm, introduced a product that contains soybean and hop extracts for the treatment of menopause-related symptoms The OTC pharmaceutical products treatment segment is categorized into non-hormonal and hormonal products. Women undergoing menopause are increasingly using over-the-counter (OTC) hormone products. Major products in this segment include topical progesterone, ibuprofen, Dehydroepiandrosterone (DHEA), and melatonin North America held the largest revenue share in 2024. There is a growing awareness about dietary requirements, which is leading to a greater demand among older women for specific nutritional needs In January 2022, Amyris, Inc. announced that it has entered into exclusive agreements to acquire the assets of a women-founded company MenoLabs, LLC. that focuses on treating menopause symptoms, conducting research of women's health and increasing society's understanding of menopause In January 2023, O Positiv, a women's health brand, launched the first-ever menopause gummy vitamin, providing menopausal women with a convenient and tasty way to manage their symptoms This report addresses: Market intelligence to enable effective decision-making Market estimates and forecasts from 2018 to 2030 Growth opportunities and trend analyses Segment and regional revenue forecasts for market assessment Competition strategy and market share analysis Product innovation listings for you to stay ahead of the curve Why Should You Buy This Report? Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments. Competitive Landscape: Explore the market presence of key players. Future Trends: Discover the pivotal trends and drivers shaping the future of the market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. Companies Featured The major companies featured in this Menopause market report include: Bayer AG Theramex AbbVie, Inc. Pure Encapsulations, LLC Dr. Reddy's Laboratories Ltd. ReNew Life Holdings Corporation Padagis Key Attributes: Report Attribute Details No. of Pages 210 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $17.79 Billion Forecasted Market Value (USD) by 2030 $24.35 Billion Compound Annual Growth Rate 5.4% Regions Covered Global Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segment Outlook2.3. Competitive InsightsChapter 3. Menopause Market Variables, Trends & Scope3.1. Market Lineage Outlook3.1.1. Parent market outlook3.2. Market Dynamics3.2.1. Market driver analysis3.2.1.1. A growing number of women experiencing menopause3.2.1.2. Increasing awareness regarding the treatment of menopausal symptoms3.2.1.3. Innovation in products available for the management of Menopause3.2.1.4. Increasing research supporting the advantages of dietary supplements3.2.2. Market restraint analysis3.2.2.1. Social stigma associated with menopause and adverse effects of products3.2.2.2. Lack of well-defined regulations3.3. Qualitative Analysis Impact of COVID-19 on Menopause Market3.4. List of Products3.5. Business Environment AnalysisChapter 4. Menopause Market Segment Analysis, By Treatment, 2018-2030 (USD Million)4.1. Menopause Market: Treatment Movement Analysis and Market Share4.2. Menopause Market: Treatment Segment Dashboard4.3. Dietary Supplements4.4. OTC Pharma Products4.4.1. OTC pharma products market, 2018-2030 (USD Million)4.4.2. Hormonal Products4.4.3. Non-hormonal productsChapter 5. Region, By Treatment, 2018-2030 (USD Million)5.1. Regional Market Dashboard5.2. Regional marketplace: Key takeawaysChapter 6. Competitive Landscape6.1. Recent Developments & Impact Analysis, By Key Market Participants6.2. Company Categorization6.3. Vendor Landscape6.4. Company Profiles For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Menopause Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤